Analyst consensus rating
MiMedx Group Analyst Rating: Strong Buy
Direct answer
MiMedx Group's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.40.
Forecast evidence checked September 6, 2026.
Get free MiMedx Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.57
- Average price target
- $7.40
- High price target
- $8.00
- Low price target
- $6.00
- Low target gap
- +31.3%
- Target upside
- +61.9%
- High target gap
- +75.1%
- Target range width
- 43.8%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- September 6, 2026
- Valid through
- September 13, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for MiMedx Group?
MiMedx Group has a verified Strong Buy consensus. The same dataset has an average price target of $7.40.
How far are MiMedx Group's low and high targets from the recorded price?
The low target implies +31.3%, while the high target implies +75.1%.
How many analysts are included in MiMedx Group's consensus?
The verified consensus includes 5 analysts.
How is MiMedx Group's target upside or downside calculated?
The average target of $7.40 is divided by the recorded price of $4.57, then one is subtracted to produce +61.9%. This does not guarantee a future return.
When was MiMedx Group's analyst forecast verified?
The data was verified on 2026-09-06. The dataset is valid through 2026-09-13.